|
|
||||||||
EDITORIAL FOCUS
Departments of 1Pediatrics, 2Physiology & Biophysics, 3Pharmacology, and 4Molecular Biology & Microbiology, School of Medicine, Case Western Reserve University, Cleveland, Ohio; and 5Departments of Medicine and Physiology, University of California, San Francisco, California
Submitted 19 September 2005 ; accepted in final form 11 August 2006
Primary airway epithelial cells grown in air-liquid interface differentiate into cultures that resemble native epithelium morphologically, express ion transport similar to those in vivo, and secrete cytokines in response to stimuli. Comparisons of cultures derived from normal and cystic fibrosis (CF) individuals are difficult to interpret due to genetic differences besides CFTR. The recently discovered CFTR inhibitor, CFTRinh-172, was used to create a CF model with its own control to test if loss of CFTR-Cl conductance alone was sufficient to initiate the CF inflammatory response. Continuous inhibition of CFTR-Cl conductance for 35 days resulted in significant increase in IL-8 secretion at basal (P = 0.006) and in response to 109 Pseudomonas (P = 0.0001), a fourfold decrease in Smad3 expression (P = 0.02), a threefold increase in RhoA expression, and increased NF-
B nuclear translocation upon TNF-
/IL-1
stimulation (P < 0.000001). CFTR inhibition by CFTRinh-172 over this period does not increase epithelial sodium channel activity, so lack of Cl conductance alone can mimic the inflammatory CF phenotype. CFTRinh-172 does not affect IL-8, IL-6, or granulocyte/macrophage colony-stimulating factor secretion in two CF phenotype immortalized cell lines: 9/HTEo pCEP-R and 16HBE14o AS, or IL-8 secretion in primary CF cells, and inhibitor withdrawal abolishes the increased response, so CFTRinh-172 effects on cytokines are not direct. Five-day treatment with CFTRinh-172 does not affect cells deleteriously as evidenced by lactate dehydrogenase, trypan blue, ciliary activity, electron micrograph histology, and inhibition reversibility. Our results support the hypothesis that lack of CFTR activity is responsible for the onset of the inflammatory cascade in the CF lung.
inflammation; Pseudomonas; cytokines; cystic fibrosis transmembrane conductance regulator; epithelial sodium channel
This article has been cited by other articles:
![]() |
N. T. N. Trinh, A. Prive, E. Maille, J. Noel, and E. Brochiero EGF and K+ channel activity control normal and cystic fibrosis bronchial epithelia repair Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L866 - L880. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Manson, D. A. Corey, N. M. White, and T. J. Kelley cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L809 - L819. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perez, A. M. van Heeckeren, D. Nichols, S. Gupta, J. F. Eastman, and P. B. Davis Peroxisome proliferator-activated receptor-{gamma} in cystic fibrosis lung epithelium Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L303 - L313. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Chappell, M. Bunz, E. Smoll, H. Dong, C. Lytle, K. E. Barrett, and D. F. McCole Hydrogen peroxide inhibits Ca2+-dependent chloride secretion across colonic epithelial cells via distinct kinase signaling pathways and ion transport proteins FASEB J, June 1, 2008; 22(6): 2023 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mizumori, Y. Choi, P. H. Guth, E. Engel, J. D. Kaunitz, and Y. Akiba CFTR inhibition augments NHE3 activity during luminal high CO2 exposure in rat duodenal mucosa Am J Physiol Gastrointest Liver Physiol, June 1, 2008; 294(6): G1318 - G1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Miller and P. B. Davis FXYD5 modulates Na+ absorption and is increased in cystic fibrosis airway epithelia Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L654 - L664. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Broughton-Head, J. Shur, M. P. Carroll, J. R. Smith, and J. K. Shute Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1240 - L1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hybiske, Z. Fu, C. Schwarzer, J. Tseng, J. Do, N. Huang, and T. E. Machen Effects of cystic fibrosis transmembrane conductance regulator and {Delta}F508CFTR on inflammatory response, ER stress, and Ca2+ of airway epithelia Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1250 - L1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Routaboul, C. Norez, P. Melin, M.-C. Molina, B. Boucherle, F. Bossard, S. Noel, R. Robert, C. Gauthier, F. Becq, et al. Discovery of {alpha}-Aminoazaheterocycle-Methylglyoxal Adducts as a New Class of High-Affinity Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1023 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chatterjee, S. Baeter, and J. Bhattacharya Endothelial and epithelial signaling in the lung Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L517 - L519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Sagel, J. F. Chmiel, and M. W. Konstan Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease Proceedings of the ATS, August 1, 2007; 4(4): 406 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Dechecchi, E. Nicolis, V. Bezzerri, A. Vella, M. Colombatti, B. M. Assael, Y. Mettey, M. Borgatti, I. Mancini, R. Gambari, et al. MPB-07 Reduces the Inflammatory Response to Pseudomonas aeruginosa in Cystic Fibrosis Bronchial Cells Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 615 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Rubin CFTR is a modulator of airway inflammation Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L381 - L382. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |